BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10509048)

  • 1. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
    Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
    Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
    [No Abstract]   [Full Text] [Related]  

  • 2. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
    Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
    Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.
    Singhal S; Mehta J; Desikan K; Siegel D; Singh J; Munshi N; Spoon D; Anaissie E; Ayers D; Barlogie B
    Bone Marrow Transplant; 1999 Jul; 24(1):13-7. PubMed ID: 10435728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
    Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
    Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
    Aulitzky WE; Neubauer A; Kolbe K; Schneller F; Busemann C; Schleiermacher E; Peschel C; Siegert W; Huber C; Huhn D
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S67-9. PubMed ID: 8769707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.
    Deininger M; Pönisch W; Krahl R; Leiblein S; Edel E; Lange T; Fiedler F; Freund M; Franke A; Pasold R; von Grünhagen U; Herold M; Dölken G; Hoffmann FA; Uhle R; Schultze W; Steglich J; Schwarzer A; Richter P; Winkelmann C; Kettner E; Dachselt K; Subert R; Schwalbe E; Doepper J; Helbig W; Niederwieser D;
    Bone Marrow Transplant; 2001 Jun; 27(11):1125-32. PubMed ID: 11551022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
    McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM
    Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
    Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
    Frassoni F; Giordano D; Podestà M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in chronic myeloid leukaemia.
    Divya
    Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
    [No Abstract]   [Full Text] [Related]  

  • 11. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
    Janssen JJ; van Rijn RS; van der Holt B; Schuurhuis GJ; Vellenga E; Verhoef GE; Ossenkoppele GJ; van den Berg E; Hagemeijer A; Släter R; Nieuwint AW; Cornelissen JJ
    Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mobilization of Ph-negative hematopoietic stem cells using rhG-CSF in patients with chronic myeloid leukemia treated with interferon-alfa. Experience of the Clinic Hospital of Barcelona].
    Carreras E
    Sangre (Barc); 1997 Apr; 42 Suppl 1():24-6. PubMed ID: 9381296
    [No Abstract]   [Full Text] [Related]  

  • 13. Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.
    Kantarjian HM; O'Brien S; Cortes JE; Shan J; Giles FJ; Rios MB; Faderl SH; Wierda WG; Ferrajoli A; Verstovsek S; Keating MJ; Freireich EJ; Talpaz M
    Cancer; 2003 Feb; 97(4):1033-41. PubMed ID: 12569603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
    Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of autotransplants in chronic myeloid leukaemia.
    Goldman JM; Deisseroth AB
    Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 17. Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine.
    Chalmers EA; Franklin IM; Kelsey S; Clarke R; Sproul AM; Goldstone AH; Hepplestone A; Watson W; Sharp S; Tansey P
    Bone Marrow Transplant; 1994; 14 Suppl 3():S38-41. PubMed ID: 7697006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
    Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
    J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.